Close Menu

NEW YORK – Opko's BioReference Laboratories announced Friday it will provide testing for a drive-through facility for SARS-CoV-2 sample collection in partnership with the New York State Department of Health.

The drive-through facility is in New Rochelle, New York, which has been the epicenter of the state's COVID-19 outbreak. The facility started testing Friday with residents in the city who have been quarantined already. The testing will be by appointment only, according to Governor Andrew Cuomo. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.